Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters

Database
Language
Affiliation country
Publication year range
1.
Cytokine ; 125: 154822, 2020 01.
Article in English | MEDLINE | ID: mdl-31470365

ABSTRACT

Plasmacytoid dendritic cells (pDCs) are major producers of type I interferons in response to activation of endosomal toll-like receptors (TLRs), e.g. TLR9. While a number of cell biological and intracellular signaling events associated with TLR9 activation in pDCs have been studied, role of free calcium (Ca2+) is not clear. We found that influx of extracellular Ca2+ is crucial for TLR9 mediated IFNα production by human pDCs. We also unraveled a role of Ca2+ in potentiating cellular uptake of self-DNA in complex with the cathelicidin antimicrobial peptide, LL37, an endogenous ligand for human TLR9 in autoimmune contexts. IFNα in response to TLR9 activation, by CpG oligonucleotides, is tuned within a window of Ca2+ concentration, through a bimodal regulatory switch, by differential engagement of Ca2+/calmodulin-dependent protein kinase II (CAMKII) and calcineurin phosphatase (CALN). Ca2+ signaling for TLR9 activation at physiologic calcium concentrations depends on CAMKII recruitment, while inhibition of TLR9 activation at supraphysiologic calcium concentrations is mediated by CALN. This bimodal regulation was masked in response to physiological peptide-DNA complexes, presumably due to potentiation of complex formation and increased cellular uptake in higher Ca2+ concentrations. Thus infection susceptibility associated with relevant clinical contexts as well as role of Ca2+ signaling in autoimmune diseases warrant further investigations for novel pathogenetic cues involving pDC function.


Subject(s)
Calcium/metabolism , Dendritic Cells/immunology , Signal Transduction/immunology , Toll-Like Receptor 9/metabolism , Antimicrobial Cationic Peptides/metabolism , Calcineurin/metabolism , Calcium/pharmacology , Calcium-Calmodulin-Dependent Protein Kinase Type 2/metabolism , Cells, Cultured , DNA/immunology , Dendritic Cells/drug effects , Dendritic Cells/metabolism , Flow Cytometry , Humans , Interferon-alpha/metabolism , Oligodeoxyribonucleotides/pharmacology , Cathelicidins
2.
Diabetes ; 65(11): 3440-3452, 2016 Nov.
Article in English | MEDLINE | ID: mdl-27561727

ABSTRACT

In obese individuals, visceral adipose tissue (VAT) is the seat of chronic low-grade inflammation (metaflammation), but the mechanistic link between increased adiposity and metaflammation largely remains unclear. In obese individuals, deregulation of a specific adipokine, chemerin, contributes to innate initiation of metaflammation by recruiting circulating plasmacytoid dendritic cells (pDCs) into VAT through chemokine-like receptor 1 (CMKLR1). Adipose tissue-derived high-mobility group B1 (HMGB1) protein activates Toll-like receptor 9 (TLR9) in the adipose-recruited pDCs by transporting extracellular DNA through receptor for advanced glycation end products (RAGE) and induces production of type I interferons (IFNs). Type I IFNs in turn help in proinflammatory polarization of adipose-resident macrophages. IFN signature gene expression in VAT correlates with both adipose tissue and systemic insulin resistance (IR) in obese individuals, which is represented by ADIPO-IR and HOMA2-IR, respectively, and defines two subgroups with different susceptibility to IR. Thus, this study reveals a pathway that drives adipose tissue inflammation and consequent IR in obesity.


Subject(s)
Dendritic Cells/metabolism , Toll-Like Receptor 9/metabolism , Adipose Tissue/metabolism , Adult , Aged , Aged, 80 and over , Female , Glycation End Products, Advanced/metabolism , HMGB1 Protein/genetics , HMGB1 Protein/metabolism , Humans , Inflammation/metabolism , Insulin Resistance/genetics , Insulin Resistance/physiology , Interferon Type I/genetics , Interferon Type I/metabolism , Intra-Abdominal Fat/metabolism , Male , Middle Aged , Receptors, Chemokine , Receptors, G-Protein-Coupled/genetics , Receptors, G-Protein-Coupled/metabolism , Toll-Like Receptor 9/genetics
SELECTION OF CITATIONS
SEARCH DETAIL